je.st
news
Tag: express
EXPRESS MARKET
2015-12-31 18:15:59| PortlandOnline
742 SW 18TH AVE - COMMENTS DUE 1-30-16 PDF Document, 1,093kbCategory: Northwest and Inner Southwest Portland (NWNW)
Tags: market
express
market express
express market
Market MoverHURRY Up for the Wall Street Express
2015-12-30 06:56:44| Biotech - Topix.net
The Wall Street Bull Market Express is leaving the station and you have two months, maybe three to run down the platform, take the leap, and latch on to the caboose. Deep into a third decade as an investment professional gives me the poetic license to call the start of the next big, generational bull market, when the Dow Jones Industrial Average at this writing is down 232 points and a number of important technical support indicators have been shattered on the downside.
Tags: street
market
express
wall
Bradley's Express ELX-Series Lavatory Earns 2015 New Product of the Year Awards from School Industry Publications
2015-12-23 11:31:10| Industrial Newsroom - All News for Today
MENOMONEE FALLS, Wis. Bradley Corp., the industry leader in designing premiere hand washing solutions for public facilities, has won two 2015 New Product of the Year Awards presented by School Planning Management and College Planning Management magazines for the companys new Express ELX-Series Lavatory System...
Tags: year
product
school
industry
Michael J Gerdin Owns Stake in Heartland Express, Inc.
2015-12-22 03:26:43| Trucking - Topix.net
Michael J Gerdin recently revealed that they own a 21.8% stake in Heartland Express, Inc. in a Schedule 13D/A disclosure that was filed with the Securities and Exchange Commission on Monday, December 21st. The investor owns 18,301,677 shares of the stock worth about $310,762,475.
Tags: inc
michael
express
owns
Mercks KEYTRUDA (pembrolizumab) Significantly Improves Survival Compared to Chemotherapy in Previously-Treated Patients with Non-Small Cell Lung Cancer Whose Tumors Express Any Level of PD-L1
2015-12-19 16:55:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. KEYNOTE-010 Published in The Lancet and to be Presented at the European Society for Medical Oncology (ESMO) Asia 2015 Congress KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced results from the pivotal KEYNOTE-010 study, the first study of its kind to evaluate the potential of an immunotherapy compared to chemotherapy based on prospective measurement of PD-L1 expression in patients with advanced non-small cell lung cancer (NSCLC). Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orCourtney Ronaldo, 908-236-1108orInvestors:Teri Loxam, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Sites : [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] next »